Logo

    cannabis testing

    Explore " cannabis testing" with insightful episodes like "Ep. 4: The State of Cannabis Testing: Safety, Evolution, and Building Trust", "Cannabis Challenges: Taxes, Legal Battles, and Industry Insights", "447: Cannabis Use & Testing at Work in New Jersey", "Milan Patel: We Are at War with Pathogens" and "Blockchain for Tracking and Validating Medical Cannabis with Robert Galarza, CEO at TruTrace Technologies Inc." from podcasts like ""Cannabis Unraveled", "Business of Cannabis: Cannabis News | Cannabis Views | Cannabis Trends", "Employment Matters", "Cannabis Equipment News" and "Healthcare Goes Digital"" and more!

    Episodes (10)

    Ep. 4: The State of Cannabis Testing: Safety, Evolution, and Building Trust

    Ep. 4: The State of Cannabis Testing: Safety, Evolution, and Building Trust

    In this episode, our focus converges on the cornerstone of cannabis testing and the indispensable role of testing labs. Joining host Jessie in this conversation is Rafael Bombonato, Executive Vice President of Quality Assurance at ACT Laboratories and Dr. Bob Miller, Chief Scientific Officer at ACT Laboratories. They first discuss the mission of testing labs in the cannabis industry, the challenges inherent in their operations, and the unyielding commitment to ethics and transparency that elevates the industry's standards. Then, the conversation flows into the danger of illicit market products, state auditing models, and the Trust In Testing program, making it more affordable and manageable for high quality testing that provides consistent and reliable results. 

    **The information, opinions, and views expressed in this podcast are those of Mr. Kater and his guests only and may not reflect the views of Curaleaf or its employees. The material and information presented here is for general information purposes only. Curaleaf does not endorse or recommend any particular product or service discussed, including products containing cannabinoids. Products discussed in this podcast may not be available to all listeners depending upon the residence state of the listener, the listener’s age, etc. Any products discussed in this podcast are not intended to diagnose, treat, cure, or prevent any disease.    

    Topics of Discussion:

    [2:29] The general purpose of testing labs in the cannabis industry. 

    [4:16] Some of the different categories that are tested in consumer safety testing. 

    [5:04] Differences between state-level and federally regulated testing. 

    [6:02] Efforts to harmonize and bring best practices across the industry. 

    [9:53] Does lab testing guarantee that consumers won't have risks associated with their cannabis?

    [12:00] The danger of illicit market products. 

    [13:38] What’s happening in the hemp space from a testing perspective. 

    [18:26] The intersection of consumer safety and business. 

    [26:11] The challenges of running a testing lab, dealing with competition, and how they face those pressures. 

    [29:07] The Trust In Testing Program and how it’s working to raise the standards as a group for all laboratories.  

    [31:30] How state auditing works and examples where it's already being done. 

    [33:17] The round robin testing in Michigan where the sample comes in blind. 

    [35:06] How the test market is evolving. 

    [41:12] Advice for consumers when it comes to product safety.

    Want to Learn More?

    Cannabis Unraveled: Instagram

    Rafael Bombonato and Dr. Bob Miller: ACT Laboratories

    Trust In Testing 

    Quotes:

    • “What we like to say at ACT Labs is what is on the label is in the bottle, so we take this quite seriously.” - Bob 2:25
    • “There are definitely those conversations that are beginning to occur, particularly with regulators. But, I think we’re probably a good bit away from being able to get such standards established.” - Bob 6:37
    • “You’re always in this race of trying to stay ahead and to try to look at all the potential opportunities, and there’s always other materials that are showing up that we haven’t been able to identify because we are lacking a standard. So, it’s always a race trying to catch up.” - Bob 16:31
    • “Part of our responsibility is to provide legally defensible results. So, we have to provide an accurate result, which in my opinion would be a disservice to our customer.” - Rafael 26:11
    • “Hopefully at the end of the day, we always tell our folks that the good guys and girls will eventually win.” - Bob 30:57
    • “It may take a long time, but the people that are above board that are ethical will eventually win. We think this will actually jumpstart this to an even greater place.” - Bob 31:05

    Cannabis Challenges: Taxes, Legal Battles, and Industry Insights

    Cannabis Challenges: Taxes, Legal Battles, and Industry Insights

    This week's stories:

    • Discover How High Fees are Challenging Cannabis Profits – Insights from Health Canada Report
    • Legal Battles, Licences Revoked – Inside the Alabama Medical Cannabis Commission's Turmoil
    • California's Tax Cuts for Cannabis: Unveiling the Strategy to Save a Struggling Industry

    Are you following the podcast yet? If not, why not? Correct this at once, here -> Follow 😉

    Check out all the main headlines on our website at businessofcannabis.com

    Business of Cannabis: New York | U.S. Cannabis Conference (cannabisnewyork.live)

    Business of Cannabis: NYC Sessions

    Cannabis Europa 

    Tweet us and let us know your thoughts on today's episode, here.

    Email us about our stories, here.

    Missed the previous episode? You can catch up with it here. 

     

    About Cannabis Daily.

    Cannabis Daily is a cannabis news and interview program from Business of Cannabis. We highlight the companies, brands, people and trends driving the cannabis industry.

    Business of Cannabis is a cannabis industry platform marrying cannabis news, video and podcast content, newsletters and online and real-world cannabis events.

    Visit Business of Cannabis online:
    http://businessofcannabis.com

    Twitter: https://twitter.com/bofc_media
    LinkedIn: https://www.linkedin.com/company/businessofcannabis
    Instagram: https://instagram.com/businessofcannabis
    Facebook: https://www.facebook.com/bofcmedia
    Spotify: http://bofc.me/spotify
    Apple: http://bofc.me/applepod
    Podcasts Online: https://bofc.me/bofclive

    447: Cannabis Use & Testing at Work in New Jersey

    447: Cannabis Use & Testing at Work in New Jersey

    In this episode, we discuss New Jersey's new marijuana law called New Jersey Cannabis Regulatory, Enforcement Assistance, and Marketplace Modernization Act (“CREAMMA”). In September 2022, the New Jersey Cannabis Regulatory Commission issued interim guidance for employers on drug testing employees for cannabis. Today’s podcast will focus on how CREAMMA effects employers, and the procedures employers are expected follow. Subscribe to our podcast today to stay up to date on employment issues from law experts worldwide.

    Host: Tara Stingley (email) (Cline Williams Wright Johnson & Oldfather, LLP / Nebraska)

    Guest Speaker: Alyssa Musmanno (email) (Day Pitney LLP / New Jersey)

    Support the show

    Register on the ELA website here to receive email invitations to future programs.

    Milan Patel: We Are at War with Pathogens

    Milan Patel: We Are at War with Pathogens

    Editor’s note: While we have continued to do the podcast weekly, it has jumped around a bit as we have scaled up our newsletter. Next week, it will return to its traditional slot on Thursdays. Thank you for your patience, and thank you for continuing to support the podcast. Click here to subscribe to our newsletter.

    This week, Milan Patel, co-founder and CEO of PathogenDx, joins the Cannabis Equipment News podcast to discuss high-speed cannabis testing. How it works, who uses it, and what (if anything) it misses. 

    Please make sure to like, subscribe and share the podcast. You could also help us out by giving the podcast a positive review. Finally, to email the podcast or suggest a potential guest, you can reach David Mantey at David @cannabisequipmentnews.com.

    Blockchain for Tracking and Validating Medical Cannabis with Robert Galarza, CEO at TruTrace Technologies Inc.

    Blockchain for Tracking and Validating Medical Cannabis with Robert Galarza, CEO at TruTrace Technologies Inc.

    Robert Galarza, CEO of TruTrace Technologies, Inc., dives into the use of blockchain technology for verifying medical cannabis products and protecting intellectual property. He also shares his leadership tips and predictions for the future of the medical cannabis industry in the US, Canada, and internationally, plus much more.

    To find out more about Impetus: https://www.meetwithimpetus.com

    Natalie Yeadon LinkedIn: https://www.linkedin.com/in/natalieyeadon/

    Impetus Digital Website: https://www.impetusdigital.com/

    Impetus Digital LinkedIn: https://www.linkedin.com/company/impetus-digital/

    Impetus Digital Twitter: https://twitter.com/impetus_digital

    Impetus YouTube: https://www.youtube.com/Impetushealthcare

    Robert Galarza: https://www.linkedin.com/in/robertmgalarza/

    TruTrace Technologies: https://trutrace.co/

    Impetus Digital has been delivering best-in-class virtual and hybrid meetings, events, and programs for global life science companies since 2008. We work closely with clinical, market access, medical affairs, marketing, medical education, and many other departments to virtualize their internal and external stakeholder meetings, such as advisory boards, learning programs, working groups, and congress engagement initiatives. We partner with clients at all stages of the product life cycle, from R&D to loss of exclusivity.

    Click the social media buttons to share this episode with your network!

    To learn more about Impetus, our services, and our tools: https://www.meetwithimpetus.com

    Natalie Yeadon LinkedIn: https://www.linkedin.com/in/natalieyeadon/

    Impetus Digital Website: Home Page

    LinkedIn: https://www.linkedin.com/company/impetus-digital/

    Twitter: impetus_digital

    YouTube: Impetus Digital

    Dr. David Cunic: All 50 States Should Legalize Medical Cannabis

    Dr. David Cunic: All 50 States Should Legalize Medical Cannabis

    This week, Dr. David Cunic, CEO and founder of UCS Advisors, discusses his life as a medical professional and serial entrepreneur. In the industry, he's known as "Dr. David," and he's been a cannabis advocate since 2009 — "before it was cool to be in cannabis."

    As a doctor of physical therapy and pain management, he is an advocate for the benefits of medical marijuana. As an entrepreneur, he has started seven cannabis businesses in five different states; overall, he's founded 13 companies in the last 18 years.

    He says he decided to enter the cannabis industry due to the misinformation surrounding cannabis as a treatment. He believes that physicians are ethically bound to show patients every possible treatment — and, until recently, most doctors were not only prohibited by states from prescribing cannabis as a medicine, but they were shunned by their medical colleagues. It wasn't until the last two to three years that the medical industry became more receptive to the benefits of medicinal use, particularly when compared to opiates for pain management.

    Dr. David also believes that all 50 states should legalize medical marijuana before recreational use is approved. He insists that if our culture is to truly view cannabis as a medicine, we need to focus on the that side first. 

    At UCS, Dr. David focuses on investment in the cannabis industry. For companies that are just starting out, his company helps secure capital investment and trains new business owners on everything from how to create a pitch deck to how to approach investors. He says many startup founders don't know how to talk to an investor. 

    An estimated 65% of business owners in cannabis and CBD are first-time business owners, and they have no idea where to start — not only when it comes to raising money, but how to run the business from an operational standpoint. Dr. David teaches strategy and helps map out a business plan.

    Although business owners don't know how to start, even fewer have an exit strategy, he says. Many harbor vague ambitions of acquisition, but less than 13% of cannabis companies get acquired — and Dr. David says it will become even less common after federal legalization. 

    The other side of UCS's businesses helps individuals invest in the cannabis industry. He says the average person is "screwed by the system when it comes to investing." It's not just a cash problem, although most people don't have $150,000 sitting around to invest. Some people, due to on their profession or a criminal record, are restricted from investing in cannabis companies. He helps them get into the industry by providing return-on-investment expectations up front, with a relatively low bar to enter — many clients start with a $5,000 investment with a 30% return in 15 months or less. If anything, investment provides an easy way to learn about the cannabis industry. 

    Dr. David has been in the healing business his entire career, and his advocacy for medical marijuana has played an important role in educating a misinformed public.

    MCR Labs Is More Than a 'Dark Box'

    MCR Labs Is More Than a 'Dark Box'

    This week, MCR Labs President Michael Kahn and Director of Business Development Jonathan Wani discuss how they protect cannabis consumers and help manufacturers improve — and protect — their businesses.

    The company started in 2013 when Kahn left his role as a chemist in the pharmaceutical industry to create a public health-centered lab that provides accurate cannabis data.

    Kahn wanted MCR to be more than a traditional lab, which often operate like a “dark box'' where samples come in and data goes out. For Kahn, it's not simply a transactional relationship with clients; they often help manufacturers contextualize data to gain a better understanding of what is happening in the facility. 

    As the industry continues to evolve and mature, the company's mission of public health has not wavered: create an environment in which fewer contaminants are found in cannabis products. 

    In samples, MCR finds everything from microbiological contaminants — bacteria and mold — to heavy metals and pesticides, as well as residual solvents and concentrates. What's encouraging, however, is that more products are passing through the lab, which saw a more consistent pass rate over the last three to four years. 

    MCR Labs is based in Framingham, Massachusetts, but recently opened its first lab outside of its home state. In January, the company began accepting and testing cannabis product samples for Pennsylvania-based medical marijuana licensees at its Allentown facility. 

    MCR was the first independent cannabis testing lab certified in Massachusetts, and the company says data accuracy and integrity will remain a top priority as it expands into additional markets.

    How a change of microbial tolerance limits affect quality control testing

    How a change of microbial tolerance limits affect quality control testing

    BofC Live is the daily news and interview program of Business of Cannabis. Business of Cannabis highlights the companies, brands, people and trends driving the sector. On this episode of BofC Live, we connect with Ellen Wang of the CannDelta team for the weekly Ask the Experts segment. Specifically, Wang answers: “How will the change of microbial tolerance limits affect quality control testing of cannabis products under the amended Cannabis Regulation?”

     

    What Australian Good Manufacturing Practices certification means for Canadian cannabis

    What Australian Good Manufacturing Practices certification means for Canadian cannabis

    BofC Live is the daily news and interview program of Business of Cannabis. Business of Cannabis highlights the companies, brands, people and trends driving the sector. On this episode of BofC Live, we connect with Ashton Abrahams, the President of Sigma Analytical Services – a cannabis testing lab in Canada. Recently, Sigma Analytical Services was granted Good Manufacturing Practices certification from the Australian Therapeutic Goods Administration. Business of Cannabis connected with Abrahams to talk about what this certification meant for Sigma Analytical Services specifically, and Canadian cannabis more generally.

    Learn more about Sigma Analytical Services.

    GemmaCert, Cannabis Testing with Guy Setton

    GemmaCert, Cannabis Testing with Guy Setton

    We are honored this week to feature Guy Setton, Chief Executive Officer of GemmaCert based in Raanana, Israel. In this episode of WeedBudz Radio, Guy and our host, Ry Russell talk about the importance of not just testing Cannabis before it goes to consumers but throughout the entire cultivation process. Testing can certainly be a costly expense for cultivators but ever so necessary. GemmaCert has created a platform that allows anyone to test their Cannabis conveniently from the comfort of their grow room. We heard Guy share some horror stories of cultivators getting through an entire harvest, send out their samples for testing, and found issues that required their yield to be disposed of. Well, this could've potentially been avoided if they tested throughout the process. Additionally, sending out samples throughout the growth cycle can have some consequences as well. First, it is an added expense for the cultivator, and second, it takes time to receive the results. This can lead to a delayed response, should adjustments need to be made. 

    GemmaCert is helping those in the industry cut costs, and have better and more reliable data when they need it. Join us and hear more about how Guy Setton found his way into the Cannabis industry and how GemmaCert could be of value for your business. 

    Support the show
    Logo

    © 2024 Podcastworld. All rights reserved

    Stay up to date

    For any inquiries, please email us at hello@podcastworld.io